BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30448697)

  • 1. Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapy.
    Yu W; Wang Y; Zhu J; Jin L; Liu B; Xia K; Wang J; Gao J; Liang C; Tao H
    Biomaterials; 2019 Feb; 192():128-139. PubMed ID: 30448697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy.
    Su Z; Xiao Z; Huang J; Wang Y; An Y; Xiao H; Peng Y; Pang P; Han S; Zhu K; Shuai X
    ACS Appl Mater Interfaces; 2021 Mar; 13(11):12845-12856. PubMed ID: 33709684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy.
    Xiong W; Qi L; Jiang N; Zhao Q; Chen L; Jiang X; Li Y; Zhou Z; Shen J
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8026-8041. PubMed ID: 33577301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
    Zheng B; Ren T; Huang Y; Guo W
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Psoriasis Effects and Mechanisms of Α-(8-Quinolinoxy) Zinc Phthalocyanine-Mediated Photodynamic Therapy.
    Liu HQ; Wang YM; Li WF; Li C; Jiang ZH; Bao J; Wei JF; Jin HT; Wang AP
    Cell Physiol Biochem; 2017; 44(1):200-214. PubMed ID: 29131032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
    Yu XN; Deng Y; Zhang GC; Liu J; Liu TT; Dong L; Zhu CF; Shen XZ; Li YH; Zhu JM
    ACS Appl Mater Interfaces; 2020 Apr; 12(15):17193-17206. PubMed ID: 32207914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework.
    Ge YX; Zhang TW; Zhou L; Ding W; Liang HF; Hu ZC; Chen Q; Dong J; Xue FF; Yin XF; Jiang LB
    Biomaterials; 2022 Mar; 282():121407. PubMed ID: 35217343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumor microenvironment responsive biodegradable CaCO
    Liu Y; Pan Y; Cao W; Xia F; Liu B; Niu J; Alfranca G; Sun X; Ma L; de la Fuente JM; Song J; Ni J; Cui D
    Theranostics; 2019; 9(23):6867-6884. PubMed ID: 31660074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.
    Lenna S; Bellotti C; Duchi S; Martella E; Columbaro M; Dozza B; Ballestri M; Guerrini A; Sotgiu G; Frisoni T; Cevolani L; Varchi G; Ferrari M; Donati DM; Lucarelli E
    J Exp Clin Cancer Res; 2020 Feb; 39(1):40. PubMed ID: 32087737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc phthalocyanine encapsulated in polymer micelles as a potent photosensitizer for the photodynamic therapy of osteosarcoma.
    Yu W; Ye M; Zhu J; Wang Y; Liang C; Tang J; Tao H; Shen Y
    Nanomedicine; 2018 Jun; 14(4):1099-1110. PubMed ID: 29462663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Affinity of Chlorin e6 to Immunoglobulin G for Intraoperative Fluorescence Image-Guided Cancer Photodynamic and Checkpoint Blockade Therapy.
    Xu J; Yu S; Wang X; Qian Y; Wu W; Zhang S; Zheng B; Wei G; Gao S; Cao Z; Fu W; Xiao Z; Lu W
    ACS Nano; 2019 Sep; 13(9):10242-10260. PubMed ID: 31397999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib inhibits doxorubicin-induced PD-L1 upregulation to improve immunosuppressive microenvironment in Osteosarcoma.
    Wang J; Hu F; Yu P; Wang J; Liu Z; Bao Q; Zhang W; Wen J
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5127-5138. PubMed ID: 36348018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.
    Sundara YT; Kostine M; Cleven AH; Bovée JV; Schilham MW; Cleton-Jansen AM
    Cancer Immunol Immunother; 2017 Jan; 66(1):119-128. PubMed ID: 27853827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse.
    Zheng B; Ren T; Huang Y; Sun K; Wang S; Bao X; Liu K; Guo W
    J Hematol Oncol; 2018 Feb; 11(1):16. PubMed ID: 29409495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of combined photodynamic and hyperthermic therapy with a new light source in an in vivo osteosarcoma tumor model.
    Nomura J; Yanase S; Matsumura Y; Nagai K; Tagawa T
    J Clin Laser Med Surg; 2004 Feb; 22(1):3-8. PubMed ID: 15117480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy.
    Wang D; Wang T; Liu J; Yu H; Jiao S; Feng B; Zhou F; Fu Y; Yin Q; Zhang P; Zhang Z; Zhou Z; Li Y
    Nano Lett; 2016 Sep; 16(9):5503-13. PubMed ID: 27525587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aloe-emodin-mediated photodynamic therapy induces autophagy and apoptosis in human osteosarcoma cell line MG‑63 through the ROS/JNK signaling pathway.
    Tu P; Huang Q; Ou Y; Du X; Li K; Tao Y; Yin H
    Oncol Rep; 2016 Jun; 35(6):3209-15. PubMed ID: 27035222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1 and PD-L1 Expression in Osteosarcoma: Which Specimen to Evaluate?
    Chen S; Guenther LM; Aronhalt A; Cardillo L; Janeway KA; Church AJ
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):482-487. PubMed ID: 31842180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer.
    Li Y; Du Y; Liang X; Sun T; Xue H; Tian J; Jin Z
    Nanoscale; 2018 Sep; 10(35):16738-16749. PubMed ID: 30156250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hiporfin-mediated photodynamic therapy in preclinical treatment of osteosarcoma.
    Sun M; Zhou C; Zeng H; Puebla-Osorio N; Damiani E; Chen J; Wang H; Li G; Yin F; Shan L; Zuo D; Liao Y; Wang Z; Zheng L; Hua Y; Cai Z
    Photochem Photobiol; 2015; 91(3):533-44. PubMed ID: 25619546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.